공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 임상 의사결정 지원 시스템 시장

Clinical Decision Support Systems

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997426
페이지 정보 영문 310 Pages
가격
US $ 5,450 ₩ 6,146,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,350 ₩ 18,439,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 임상 의사결정 지원 시스템 시장 Clinical Decision Support Systems
발행일 : 2021년 04월 페이지 정보 : 영문 310 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 임상 의사결정 지원 시스템 시장 규모는 분석기간(2020-2027년)에 10.4%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 11억 달러에서 2027년에는 22억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 하드웨어는 분석기간 중 9.3%의 CAGR을 나타내고, 6억 6,950만 달러에 달할 전망입니다.

세계의 임상 의사결정 지원 시스템 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Elsevier BV
  • Epic Systems Corporation
  • Hearst Health
  • IBM Corporation
  • McKesson Corporation
  • MEDITECH
  • Philips Healthcare
  • Wolters Kluwer Health

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 43개사
LSH 21.04.07

Abstract:

Global Clinical Decision Support Systems Market to Reach $2.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Decision Support Systems estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Hardware, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$669.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 13.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $322 Million, While China is Forecast to Grow at 9.8% CAGR

The Clinical Decision Support Systems market in the U.S. is estimated at US$322 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$375.7 Million by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Services Segment to Record 9.6% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$380 Million in the year 2020 will reach a projected size of US$725.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$253.1 Million by the year 2027.

Select Competitors (Total 43 Featured) -

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Elsevier BV
  • Epic Systems Corporation
  • Hearst Health
  • IBM Corporation
  • McKesson Corporation
  • MEDITECH
  • Philips Healthcare
  • Wolters Kluwer Health

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Clinical Decision Support Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Cloud-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for On-premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for On-premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for On-premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Standalone CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Standalone CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Standalone CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Integrated CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Integrated CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Integrated CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Conventional CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Conventional CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Conventional CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Advanced CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Advanced CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Advanced CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Therapeutic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Therapeutic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Therapeutic CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Diagnostic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: World Historic Review for Diagnostic CDSS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: World 15-Year Perspective for Diagnostic CDSS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 37: USA Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: USA Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: USA 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 46: USA Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: USA Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: USA 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 49: USA Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: USA Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: USA 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 52: Canada Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Canada Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Canada 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 55: Canada Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Canada Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Canada 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 58: Canada Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Canada Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Canada 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 61: Canada Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Canada Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Canada 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 64: Canada Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Canada Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Canada 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 67: Japan Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Japan Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Japan 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 70: Japan Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Japan Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Japan 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 73: Japan Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Japan Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Japan 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 76: Japan Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Japan Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Japan 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 79: Japan Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Japan Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Japan 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 82: China Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: China Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: China 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 85: China Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: China Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: China 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 88: China Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: China Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: China 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 91: China Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: China Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: China 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 94: China Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: China Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: China 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 97: Europe Current & Future Analysis for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 98: Europe Historic Review for Clinical Decision Support Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Europe 15-Year Perspective for Clinical Decision Support Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 100: Europe Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Europe Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Europe 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 103: Europe Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Europe Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Europe 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 106: Europe Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Europe Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Europe 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 109: Europe Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Europe Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Europe 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 112: Europe Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Europe Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Europe 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 115: France Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: France Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: France 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 118: France Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: France Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: France 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 121: France Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: France Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: France 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 124: France Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: France Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: France 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 127: France Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: France Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: France 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 130: Germany Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Germany Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Germany 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 133: Germany Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Germany Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Germany 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 136: Germany Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Germany Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Germany 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 139: Germany Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Germany Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Germany 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 142: Germany Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Germany Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Germany 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 145: Italy Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Italy Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Italy 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 148: Italy Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Italy Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Italy 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 151: Italy Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Italy Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Italy 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 154: Italy Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Italy Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Italy 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 157: Italy Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Italy Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Italy 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 160: UK Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: UK Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: UK 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 163: UK Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: UK Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: UK 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 166: UK Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: UK Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: UK 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 169: UK Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: UK Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: UK 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 172: UK Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: UK Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: UK 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 175: Rest of Europe Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Rest of Europe Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Rest of Europe 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 178: Rest of Europe Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Europe Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of Europe 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Europe Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Europe Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Europe 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Europe Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Europe Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Europe 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of Europe Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Europe Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Europe 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 190: Asia-Pacific Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Asia-Pacific Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Asia-Pacific 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 193: Asia-Pacific Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Asia-Pacific Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Asia-Pacific 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 196: Asia-Pacific Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Asia-Pacific Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Asia-Pacific 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 199: Asia-Pacific Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Asia-Pacific Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Asia-Pacific 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 202: Asia-Pacific Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Asia-Pacific Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Asia-Pacific 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 205: Rest of World Current & Future Analysis for Clinical Decision Support Systems by Component - Hardware, Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Rest of World Historic Review for Clinical Decision Support Systems by Component - Hardware, Software and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Rest of World 15-Year Perspective for Clinical Decision Support Systems by Component - Percentage Breakdown of Value Sales for Hardware, Software and Services for the Years 2012, 2020 & 2027
    • TABLE 208: Rest of World Current & Future Analysis for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Rest of World Historic Review for Clinical Decision Support Systems by Delivery mode - Cloud-based and On-premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Rest of World 15-Year Perspective for Clinical Decision Support Systems by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based and On-premise for the Years 2012, 2020 & 2027
    • TABLE 211: Rest of World Current & Future Analysis for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Rest of World Historic Review for Clinical Decision Support Systems by Product - Standalone CDSS and Integrated CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Rest of World 15-Year Perspective for Clinical Decision Support Systems by Product - Percentage Breakdown of Value Sales for Standalone CDSS and Integrated CDSS for the Years 2012, 2020 & 2027
    • TABLE 214: Rest of World Current & Future Analysis for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Rest of World Historic Review for Clinical Decision Support Systems by Application - Conventional CDSS and Advanced CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Rest of World 15-Year Perspective for Clinical Decision Support Systems by Application - Percentage Breakdown of Value Sales for Conventional CDSS and Advanced CDSS for the Years 2012, 2020 & 2027
    • TABLE 217: Rest of World Current & Future Analysis for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Rest of World Historic Review for Clinical Decision Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Rest of World 15-Year Perspective for Clinical Decision Support Systems by Type - Percentage Breakdown of Value Sales for Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43
Back to Top
전화 문의
F A Q